0002096691-25-000001.txt : 20251113 0002096691-25-000001.hdr.sgml : 20251113 20251113143936 ACCESSION NUMBER: 0002096691-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251113 DATE AS OF CHANGE: 20251113 EFFECTIVENESS DATE: 20251113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Carolina Molecular Inc. CENTRAL INDEX KEY: 0002096691 ORGANIZATION NAME: EIN: 334741085 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-563924 FILM NUMBER: 251477478 BUSINESS ADDRESS: STREET 1: 133 SOUTHCENTER COURT STE 400 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 9194217778 MAIL ADDRESS: STREET 1: 133 SOUTHCENTER COURT STE 400 CITY: MORRISVILLE STATE: NC ZIP: 27560 D 1 primary_doc.xml X0708 D LIVE 0002096691 Carolina Molecular Inc. 133 SOUTHCENTER COURT STE 400 MORRISVILLE NC NORTH CAROLINA 27560 9194217778 DELAWARE None None Corporation true 2025 Trent Carrier 133 Southcenter Court Ste 400 Morrisville NC NORTH CAROLINA 27560 Executive Officer Director John Corliss 133 Southcenter Court Ste 400 Morrisville NC NORTH CAROLINA 27560 Director Max Weis 133 Southcenter Court Ste 400 Morrisville NC NORTH CAROLINA 27560 Director Biotechnology Decline to Disclose 06b false 2025-09-17 false true false 0 1700000 1125000 575000 false 8 0 0 0 Proceeds will be used for working capital, which may include normal compensation to executive officers. false Carolina Molecular Inc. Trent Carrier Trent Carrier President 2025-11-06